Senova Technology

Semaglutide lowers blood glucose levels by binding to GLP-1 receptors to promote insulin secretion in a glucose concentration-dependent manner and inhibit glucagon secretion. At the same time, it also slows down stomach emptying, reduces appetite and food intake, and helps with weight control.